课题基金 / 基金详情

Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents

Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
癌症化学预防剂的1期和2期临床试验
批准号：
7944363
负责人：
SCOTT M LIPPMAN
金额：
$213.6万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
项目状态：
已结题
起止时间：
2003-09-30 至 2012-09-29
来源：
https://reporter.nih.gov/project-details/7944363
关键词：
PhaseClinicalTrialsCancerChemopreventive

项目摘要

项目成果

SCOTT M LIPPMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this procurement is to conduct multiple early phase (Phase 1 and Phase 2) clinical trials of the National Cancer Institute (NCI), Division of Cancer Prevention (DCP)-sponsored cancer preventive agents and to establish the infrastructures composed of one or more collaborating institutions that will perform these trials. The trials will assess the cancer preventive potential of various agents by evaluating the biologic effects of these agents on their molecular targets and by determining clinically relevant correlates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CA: Administrative Core
Biology of the Prostate Cancer Prevention Trial (PCPT)
Core--Pathology/Genotyping
CORE A "Administration Core"
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data